跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 666 条关于
“LRK-4189”
全部
666
临床试验
333
药物
283
机构
11
资讯
39
去年
Larkspur Biosciences Unveils First-in-Class PIP4K2C Degrader LRK-4189 for Microsatellite Stable Colorectal Cancer
9个月前
Larkspur Biosciences Initiates First-in-Human Trial of Novel Protein Degrader LRK-4189 for Colorectal Cancer
2个月前
Bipartisan Senate Push Revives $35 Insulin Cap for Private Insurance and Uninsured Patients
5个月前
ProSomnus Receives FDA Clearance for First Theragnostic Sleep Apnea Device Combining Oral Therapy with Continuous Monitoring
去年
Novel Mini-Protein AKY-1189 Shows Promise in Targeted Radiation Delivery for Multiple Cancer Types
去年
Ark Clinical Research Launches Mobile Unit to Enhance Decentralized Clinical Trials and Diversity
去年
Citius Pharma Advances Mino-Lok Approval Pathway Following FDA Meeting
去年
Ark Clinical Research to Launch Mobile Unit for Decentralized Trials
去年
BridgeBio's BBP-418 Completes Enrollment in Phase 3 Trial for LGMD2I/R9
去年
Tevogen Bio's TVGN 489 Shows Promise in High-Risk COVID-19 Patients
第 1 页,共 4 页
上一页
下一页